Later, the benefits of Tian Lu's original visit to the United States became more and more apparent.

With the support of Professor Locke and the San Francisco Medical Center, the initial results are enough to convince many hospitals and physicians to join their clinical collaborations and find opportunities to provide training bases for young neurosurgeons.

And during the two years at Scripps Research Institute, the benefits to Tian Lu were no different.

Because he made excellent results in the institute at the beginning, it attracted the attention of many bigwigs, and now that his academic status and achievements have come up, it is much easier to cooperate with them, and any laboratory will easily accept the request of Tian Lu to send people for training.

In addition, the most important thing is that the doctors at the San Francisco Medical Center will not be able to change jobs to work in Kyoto, but there are definitely not a few researchers at the Scripps Research Institute who are willing to follow the road of the field!

Of course, Tian Lu would never be stupid enough to poach the professors and researchers of the institute, those people are the foundation of Scripps, but don't forget, there are hundreds of PhDs here, and most of them are people who are doing postdoctoral research, and there are definitely a few who can stay in Scripps in the future, and they are the main target of Tian Lu. And for the Scripps Research Institute, this is a natural favor.

The next day, Tian Lu gave a special lecture for nearly 200 doctors.

There are not many Chinese people who are doctors in the United States, especially good specialties such as dermatology and surgery, which are even rarer, but in the field of basic scientific research, yellow skin is a very important piece of the puzzle.

Scripps Research Institute is no exception, and there are at least 30 Chinese students here!

In the morning, the content of the lecture was scientific research thinking and methods, and in the afternoon, Tian Lu's speech was about several basic research topics that he has led in the past few years. The content ranges from topic setting, feasible research, formulation of plans, to final implementation, statistics, analysis, summary, and even a special training in writing scientific research papers. Covers almost everything a scientist must master!

Of course, the introduction of the Institute of Neurobiology and the Future Biology Laboratory is indispensable!

Here, Tian Lu played a small time difference, and there was not much introduction to the current laboratory situation in the slides of Jingmei. At most, it was just a show of the internal equipment and so on, and the focus was on the newly acquired building, because a week after the contract was signed. The four big characters of the Lefu Building were demolished and replaced by the four giant characters of "Future Creature"!

In addition to the all-round display of the newly purchased future biological building, Tian Lu also listed the list of experimental instruments and equipment in the laboratory, of course, including the equipment that has been ordered or planned to be purchased in the second half of the year.

Such scientific research conditions. It's not bad compared to Scripps Research Institute!

Therefore, when Tian Lu finally listed the scientific research fields and subject directions that the laboratory and research institute will expand in the next three years, and gave the staffing and funding guarantee plan, many people's faces showed contemplation!

First-class scientific research environment, first-class scientific research funding. And first-class experimental equipment!

The only thing that makes people a little uncomfortable is that most of the fields are completely new to the laboratory or research institute, and there is no foundation.

But a blank piece of paper is good for painting, isn't it?

To go to a mature and leading scientific research institution, even if you are a PhD from the Scripps Research Institute, or even complete postdoctoral research, you must start step by step in the hands of the big guys. If I go to a worse institution, although I can get enough attention and resources immediately, I am far behind in terms of scientific research conditions.

There are very hardware conditions, and you can show your strengths, and the most important thing is that there is Tian Lu, the world's well-known scholar guidance, such a working environment, for everyone really has a well-known attraction!

The silence of the audience made Tian Lu extremely satisfied, of course, unlike when he had dinner in Tokyo a few days ago, Tian Lu did not say so bluntly this time, but left his contact information after giving these superior conditions.

However, Tian Lu believes that he will definitely be extremely busy at tonight's banquet......

At the end of the Scripps Research Institute tour, Tian Lu was also very satisfied and got on the plane to Seattle.

Recruiting talents is a long-term job, especially for these doctoral students, most of whom have not yet graduated, so there is no rush to have fun. If you plant the cause today, it may take a year or even two or three years to get the fruit, and you can't be in a hurry, so Tian Lu has the patience to wait.

Besides, there are many opportunities in the long journey!

At the headquarters of Nofi, in addition to guiding the laboratory program of new compounds, Tian Lu also had a general understanding of the first small molecule compounds to be transferred.

The compound that can close the blood-brain barrier has entered phase III clinical trials!

A large number of test subjects, i.e., patients with various central nervous system diseases, have been recruited and have begun to be used. According to Nuofi's plan, at least 3,000 patients will be recruited in the phase III clinical trial, and clinical application observation will be conducted for at least one and a half years to confirm the efficacy and safety of the new drug, and then it can apply for FDA approval.

This is a critical stage!

Generally speaking, the success rate of R&D drugs that can successfully pass phase III clinical trials is less than one-third, and because huge manpower and material resources have been invested in the front, once it fails, the losses caused by it can be imagined!

In fact, most of the company's annual R&D investment is lost to these clinical trials.

However, whether it is for Nofi or for Tian Lu, basically no one has considered the possibility of xing in this regard. Tian Lu said that he naturally has enough confidence in knowing the future, but for Nofi Company, he is also full of confidence, even compared to Tian Lu!

Without him, the performance of small molecule compounds in front is too outstanding!

The performance of the laboratory is almost perfect, and after entering the phase I clinical trial, the toxicity and side effects are very small, and the safety is very satisfactory. In the case of the second phase of clinical trial, the safety xing will continue to be maintained, and the efficacy will be even better!

It can be said that although it has just entered the phase III clinical trial, it is full of confidence that Nofi is already planning the phase IV clinical trial after the market.

It is precisely for this reason that the patent for the anti-Alzheimer's disease compound that has just been purchased has been highly valued by the R&D department, and almost all relevant personnel attended the exchange meeting on the day of Tian Lu's visit. Driven by profits, the energy that these multinational corporations can exert is far beyond the imagination of ordinary people......

When they left Seattle, the rest of the trip for the three of them was taken over by Ascone.

Ascone's headquarters in Dallas, a city that Tianlu has never been to before, also arranged a trip to Sanri. For this new partner, Tian Lu didn't want to spend more time communicating and communicating, but he really didn't have that time, so he entered a tense meeting from the first time he got off the plane.

In fact, whether it is in Nofi or Ascone, Tian Lu's work is very simple, that is, to explain in detail the compound patents that have just been transferred, especially the analysis and summary of the test results of various aspects carried out in the future biological laboratory in the early stage, and to provide reasonable suggestions for the follow-up laboratory work of the two companies.

In this regard, everyone's interests are aligned.

The sales share of the anti-Parkinson's compounds acquired by Ascone Pharmaceuticals is nearly 23% in the later stage of Future Biologics, and the sales share of the compounds acquired by Norfi is as high as 33% in the later stage!

Such a sharing ratio is enough for Tian Lu to spare no effort when communicating!

Clinical trials are not a shortcut, the first phase of small-scale testing of pharmacokinetics, safety and toxicity and side effects, etc., the second phase of medium-scale testing of safety and efficacy, and the third phase of large-scale continuous investigation of various parameters, it can be said that each phase of clinical trials before the drug is marketed needs volunteers or patients to cooperate, and the experimental data must accumulate a sufficient amount. So even if the two companies do their best to secure the funding needed for the experiment, it will take time to recruit volunteers and patients, and it will take even more time to collect the data!

But the lab stage is different.

A complete and feasible protocol can sometimes save nearly half of the time for both companies!

For the two companies, they have invested so much money in the early stage, and they have to pay a high sales share in the later stage, so they naturally hope that the sooner the drug is listed, the better, especially Ascone, the anti-Parkinson's drug is not without competitors, on the contrary, the competition is extremely fierce, and the company can have more initiative to go public as soon as possible!

Tian Lu's help is extremely important.

I don't have time to draw up a detailed R&D plan, but I can still do it if I give a rough plan, especially some experimental plans that take a long time. Moreover, with Tian Lu's academic status in the field of basic scientific research, the communication between him and Ascom's R&D department was as easy as when he was in Nofi, and those scientific researchers did not have the sense of distrust that Tian Lu had when he first came, and gave him enough trust.

So in just three days, it's almost enough. After three ri, the three of them hurried to the airport and got on the plane to the next stop.

Next stop is New York......

This week is too busy, so the quantity and quality are down, and the code word is also in a hurry, and everyone is more forgiving.

It's a little better today, and there's another chapter in the evening. (To be continued.) )